GRIT and Quangang Forge Strategic Partnership to Accelerate Localization of Interleukin-2

SHANGHAI, May 31, 2024 /PRNewswire/ — Shanghai Grit Biotechnology Co., Ltd. (GRIT) and Shandong Quangang Pharmaceutical Co., Ltd. (Quangang) announced the establishment of a formal strategic partnership to leverage both parties’ R&D capabilities in innovative T-cell therapy. The…